The Peptide Pandemonium: When Lobbying Trumps Science The Food and Drug Administration (FDA) has been quietly allowing the interests of influential individuals to override scientific rigor in its decision making processes.
A recently concluded committee meeting, heavily influenced by Health and Human Services Secretary Robert F. Kennedy Jr. , voted to lift restrictions on the manufacture of peptides for human use.
This move has far reaching implications that warrant serious attention.